Key statistics
On Thursday, Insulet Corp (P2OD34:SAO) closed at 44.36, 0.00% above its 52-week low of 44.36, set on Feb 12, 2026.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 44.36 |
|---|---|
| High | 44.36 |
| Low | 44.36 |
| Bid | 39.24 |
| Offer | 42.54 |
| Previous close | 44.36 |
| Average volume | 2.00 |
|---|---|
| Shares outstanding | -- |
| Free float | -- |
| P/E (TTM) | -- |
| Market cap | -- |
| EPS (TTM) | -- |
Data delayed at least 15 minutes, as of Feb 12 2026.
More ▼
Press releases
- Insulet Launches Omnipod® 5 and Omnipod Discover™ in the Middle East to Transform Diabetes Care
- Insulet to Announce Fourth Quarter and Full Year 2025 Financial Results on February 18, 2026
- Insulet Redefines Diabetes at CES with "Liveable Technology" — A New Frontier in Human-Centered Connected Health
- Insulet to Participate in 44th Annual J.P. Morgan Healthcare Conference
- Insulet Expands Omnipod® U.S. Recycling Program, Diverting Millions of Pods from Landfills and Creating a More Sustainable Future
- Insulet Announces FDA 510(k) Clearance of Omnipod® 5 Algorithm Enhancements that Redefine Insulin Delivery and Simplify the Pod Experience
- Insulet Outlines Long-Term Strategy to Drive Growth and Value Creation at 2025 Investor Day
More ▼
